PMID- 16543245 OWN - NLM STAT- MEDLINE DCOM- 20060721 LR - 20211203 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 281 IP - 20 DP - 2006 May 19 TI - Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc. PG - 13957-63 AB - The induction of vascular endothelial growth factor (VEGF) is an essential feature of tumor angiogenesis. Hypoxia is a potent stimulator of VEGF expression, and hypoxia-inducible factor-1 (HIF-1) is considered to be critical for this induction. However, we have previously demonstrated that induction of VEGF by hypoxia was preserved when HIF-1alpha was silenced. We sought to better define the molecular basis of this HIF-1-independent regulation. In colon cancer cells, hypoxia stimulated multiple K-ras effector pathways including phosphatidylinositol 3-kinase. VEGF promoter deletion studies identified a novel promoter region between -418 and -223 bp that was responsive to hypoxia in a PI3K/Rho/ROCK-dependent manner. Electrophoretic mobility shift assays identified a fragment between -300 and -251 bp that demonstrated a unique shift only in hypoxic conditions. Inhibition of PI3K or ROCK blocked the formation of this complex. A binding site for c-Myc, a target of ROCK, was identified at -271 bp. A role for c-Myc in the hypoxic induction of VEGF was demonstrated by site-directed mutagenesis of the VEGF promoter and silencing of c-Myc by small interfering RNA. Collectively, these findings suggest an alternative mechanism for the hypoxic induction of VEGF in colon cancer that does not depend upon HIF-1alpha but instead requires the activation of PI3K/Rho/ROCK and c-Myc. FAU - Mizukami, Yusuke AU - Mizukami Y AD - Gastrointestinal Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA. FAU - Fujiki, Kotoyo AU - Fujiki K FAU - Duerr, Eva-Maria AU - Duerr EM FAU - Gala, Manish AU - Gala M FAU - Jo, Won-Seok AU - Jo WS FAU - Zhang, Xiaobo AU - Zhang X FAU - Chung, Daniel C AU - Chung DC LA - eng GR - CA92594/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20060316 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Intracellular Signaling Peptides and Proteins) RN - 0 (Proto-Oncogene Proteins c-myc) RN - 0 (Vascular Endothelial Growth Factor A) RN - EC 2.7.11.1 (Protein Serine-Threonine Kinases) RN - EC 2.7.11.1 (rho-Associated Kinases) SB - IM MH - Base Sequence MH - Colonic Neoplasms/metabolism MH - *Gene Expression Regulation, Neoplastic MH - Humans MH - *Hypoxia MH - Intracellular Signaling Peptides and Proteins MH - Models, Biological MH - Molecular Sequence Data MH - Phosphatidylinositol 3-Kinases/*metabolism MH - Promoter Regions, Genetic MH - Protein Serine-Threonine Kinases/*metabolism MH - Proto-Oncogene Proteins c-myc/*metabolism MH - Vascular Endothelial Growth Factor A/genetics/*metabolism MH - rho-Associated Kinases EDAT- 2006/03/18 09:00 MHDA- 2006/07/22 09:00 CRDT- 2006/03/18 09:00 PHST- 2006/03/18 09:00 [pubmed] PHST- 2006/07/22 09:00 [medline] PHST- 2006/03/18 09:00 [entrez] AID - S0021-9258(20)78037-3 [pii] AID - 10.1074/jbc.M511763200 [doi] PST - ppublish SO - J Biol Chem. 2006 May 19;281(20):13957-63. doi: 10.1074/jbc.M511763200. Epub 2006 Mar 16.